The Short Version
Evidence supports that DMSO can reduce inflammatory markers in human-derived systems and has some human clinical evidence consistent with anti-inflammatory activity. The main limitation is that the strongest support comes from ex vivo and mechanistic studies, while clinical trials are smaller, mixed, and condition-specific. So the general claim is supported, but it overstates how firmly clinical benefit has been established in living patients.